RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Covid-19 levels in the United States are high and rising, flu season is approaching quickly and RSV cases are already ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

Older adults and newborn babies are among those ... option — is both safe and effective at preventing serious RSV infection in newborns, and protects babies even better than the vaccine given ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

It’s that time of year again: the dreaded cold and flu season is on the horizon. But lurking in the shadows is a more sinister threat: RSV.

released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of Arexvy (Respiratory Syncytial Virus Vaccine) when co ...

RSV, a common respiratory virus that usually causes mild, cold-like symptoms, is on the rise. While usually innocuous in adults, RSV cases in children and the elderly can be far more serious.